BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026
Go back to BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026| (NASDAQ: BBIO) | Delayed: 74.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.76 | 52 Week High | $ | |||
| Open | $74.76 | 52 Week Low | $ | |||
| Day High | $74.76 | P/E | N/A | |||
| Day Low | $74.76 | EPS | $ | |||
| Volume | 4 | |||||
